Alpha Dna Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
Alpha Dna Investment Management LLC
- $257 Million
- Q4 2024
A detailed history of Alpha Dna Investment Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 439 shares of REGN stock, worth $298,520. This represents 0.12% of its overall portfolio holdings.
Number of Shares
439
Previous 630
30.32%
Holding current value
$298,520
Previous $662,000
52.87%
% of portfolio
0.12%
Previous 0.25%
Shares
9 transactions
Others Institutions Holding REGN
# of Institutions
1,486Shares Held
85.6MCall Options Held
1.53MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.31 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.74 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.8 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.29 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.22 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...